Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
This analytic paper reviews the evidence on effectiveness, benefits and limitations of one of the best-studied antiplatelet agents – acetylsalicylic acid (ASA). The results of clinical trials, together with so called “gastro-toxicity” of ASA, or Aspirin, and a need for long-term anti-platelet therap...
Saved in:
Main Author: | O. V. Averkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2010-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2043 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01) -
Anti-platelet therapy in coronary heart disease
by: O. V. Ermakova, et al.
Published: (2010-02-01) -
Anti-platelet therapy algorithms in women
by: O. N. Tkacheva, et al.
Published: (2011-02-01) -
Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
by: V. V. Rafalsky, et al.
Published: (1970-01-01) -
ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
by: E. N. Dankovtseva
Published: (2015-09-01)